Activated Dendritic Cell Membrane‐Engineered Nanoformulation of Metallo‐Immunomodulators as Lysosome‐Targeted Adjuvants for Synergistic Cancer Immunotherapy
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202502409 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Heying Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, West China Second University Hospital, Sichuan University, Chengdu…. Hauptthemen laut MEDLINE: Lysosomes, Immunotherapy, Dendritic Cells, Adjuvants, Immunologic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Hong Kong Scholars Program, Sichuan Provincial People's Hospital Research Fund.
Abstract (Originalsprache)
Combination of chemotherapy and cancer immunotherapy has shown substantial clinical promise. However, the immunosuppressive tumor microenvironment (TME) poses a critical barrier to this combination therapy. Here, a tumor lysosome‐targeted immunomodulatory strategy based on a biomimetic nanoadjuvant is presented, which effectively overcomes the immunosuppressive TME and demonstrates enhanced therapeutic efficacy when combined with chemotherapy. This nanoadjuvant integrates Fe‐DOX coordination nanoparticles, a MnCO 3 shell, TLR7/8 agonist (R848), and a mature dendritic cell membrane (DCM) coating. The resulting DCM@(Fe‐DOX‐Mn‐R848) nanoadjuvant induces immunogenic cell death in tumor cells via lysosomal‐mitochondrial cascade destruction. Concurrently, it activates the cGAS‐STING signaling pathway to promote dendritic cell maturation and repolarize tumor‐associated macrophages from M2 to M1 phenotype, thereby effectively enhancing CD8 + T cell activation and tumor therapeutic efficacy. When combined with PD‐L1 blockade therapy, the nanoadjuvant demonstrates enhanced efficacy in murine models of primary and recurrent triple‐negative breast cancer, establishing durable immune memory. This platform demonstrates significant potential in overcoming immunosuppressive TME and advancing combination therapy through lysosome‐targeting drug delivery technology, revealing promising prospects for cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, West China Second University Hospital, Sichuan University, Chengdu, 610041, China.
- Chinese Academy of Sciences Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics and University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing, 10…
- Department of Chemistry, City University of Hong Kong, 83 Tat Chee Avenue, Kowloon, Hong Kong, 999077, China.
- Sichuan Provincial Key Laboratory for Human Disease Gene Study and the Center for Medical Genetics, Department of Laboratory Medicine, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School o…
- Sichuan-Chongqing Joint Key Laboratory of Pathology and Laboratory Medicine, Jinfeng Laboratory, Chongqing, 401329, China.
- Research Unit for Blindness Prevention, Chinese Academy of Medical Sciences (2019RU026), Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Chengdu, Sichuan, 610072, China.
ORCID-Profile: Dongqing Wang
Förderung
- National Natural Science Foundation of China
- Hong Kong Scholars Program
- Sichuan Provincial People's Hospital Research Fund
- Guangdong Basic and Applied Basic Research Foundation
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Chen, H., Cai, X., Zhang, J., Sun, H., Zhang, J., Chen, J., Yang, Z., & Wang, D. (2025). Activated Dendritic Cell Membrane‐Engineered Nanoformulation of Metallo‐Immunomodulators as Lysosome‐Targeted Adjuvants for Synergistic Cancer Immunotherapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202502409
Vancouver
Chen H, Cai X, Zhang J, Sun H, Zhang J, Chen J, et al. Activated Dendritic Cell Membrane‐Engineered Nanoformulation of Metallo‐Immunomodulators as Lysosome‐Targeted Adjuvants for Synergistic Cancer Immunotherapy. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202502409
BibTeX
@article{Chen2025,
author = {Chen, Heying and Cai, Xiaomeng and Zhang, Jiayu and Sun, Hongyan and Zhang, Jie and Chen, Jun and Yang, Zhenglin and Wang, Dongqing},
title = {Activated Dendritic Cell Membrane‐Engineered Nanoformulation of Metallo‐Immunomodulators as Lysosome‐Targeted Adjuvants for Synergistic Cancer Immunotherapy},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202502409}
}
EUVIMED